Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: IMO the most important part of this Quarterly

When the company clearly stated that a minimum of 10% of all settlement funds would be used to buy back shares, why do you say the O/S will increase to overe 400 Million?

Thank you for you reply.

Share
New Message
Please login to post a reply